Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Please Support Common Dreams This #GivingTuesday

Our staff has grown and our coverage of the climate emergency, COVID-19, and rising authoritarianism has intensified over the last two years. But, our expenses during the pandemic have gone up as well. This has been one of the toughest years we’ve ever faced. Donations are down. Traffic to the website from Google and Facebook have inexplicably fallen off a cliff. If we have any chance of meeting our fundraising targets for the year, we need this to be the best #GivingTuesday ever. Though our content is free to all, less than 1% of our readers ever make a donation. We're counting on you. Can you make that gift today to help Common Dreams end the year strong?

Please Help This #GivingTuesday -- Though our content is free to all, less than 1% of our readers give. We’re counting on you. Please help Common Dreams end the year strong.

Key to keeping the death toll down for those with virulent infections is the availability of mechanical ventilators, machines that help people breathe when their lungs can't breathe on their own. (Image: Screengrab/CBC)

Key to keeping the death toll down for those with virulent infections is the availability of mechanical ventilators, machines that help people breathe when their lungs can't breathe on their own. (Image: Screengrab/CBC)

A Low-Cost Ventilator Could Be Available Next Year. But Will It?

Thomas Neuburger

There's quite a lot to write about coronavirus. There's the coming need for hospital beds ("These Places Could Run Out of Hospital Beds as Coronavirus Spreads"), the need for parts for ventilators ("Volunteers 3D-Print Unobtainable $11,000 Valve For $1 To Keep Covid-19 Patients Alive; Original Manufacturer Threatens To Sue"), the need to understand the new working-from-home environment ("Working From Home? Zoom Tells Your Boss If You're Not Paying Attention"), and so on.

But let's start with ventilators.

Coronavirus-19 is a respiratory disease, "an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)." It is not the flu. It attacks the lungs and those whose respiratory or immune systems are weak are particularly vulnerable to severe infections, which often result in death.

Key to keeping the death toll down for those with virulent infections is the availability of mechanical ventilators, machines that help people breathe when their lungs can't breathe on their own. After recovery from the coronavirus infection, normal breathing capability is restored and the ventilator is removed. Access to ventilators is critical to saving lives in a crisis like this, more important even than hospital beds, since ventilators can be used almost anywhere — in a triage setting, for example.

Of special importance are portable, low-cost ventilators. (Note the picture at the top, showing a ventilator in a hospital setting — not very portable, not very cheap.)

Fortunately, such a low-cost device exists, or will soon. As MIT Technology Review reported:

We need more ventilators. Here’s what it will take to get them. 

As a Stanford postdoc a decade ago, Matt Callaghan created the designs for a streamlined, low-cost ventilator that hospitals could stockpile, to prepare for the possibility of a global pandemic.

But when he went to cofound a company, One Breath, he and colleagues determined the immediate need was producing cheaper ventilators for critical care in the developing world, where chronic respiratory illnesses are among the leading causes of death.

The company raised several million dollars, set up manufacturing in Southeast Asia and finally expected to begin production for its initial markets within the next 12 months.

Here's what the new ventilator will look like; compare that to the ventilator pictured at the top:

A rendering of One Breath's ventilator

The obstacles to retooling this device for first-world use are many, as you might imagine. "To begin manufacturing devices suited for an escalating pandemic – which entail different standards, features and batteries ­– Callaghan says they would need to raise additional funds, lock-in contracts and secure fast-track regulatory approvals, including from the US Food and Drug Administration" — and that just lists a few of the roadblocks.

Chief among them, of course, is money, which brings us to the "free market." Again from the Review:

Adding factory capacity also costs a lot of upfront money, creating real risks for these businesses, since it’s possible hospitals won’t need as many ventilators as the worst-case scenarios suggest.

“Who will pay for all the extra ventilators even if the company can ramp up?” said Kenneth Lutchen, dean of the Boston University’s College of Engineering and a professor of biomedical engineering, who is focused on developing safer mechanical ventilators, in an email. “Presumably at some point this crisis will play itself out and the hospitals will have far more ventilators than they need until the next crises.”

“There needs to be an incentivized business model to hit the go button for ramping up manufacturing and government likely needs to figure out how to successfully engage,” he added.

Who will pay indeed? "An incentivized business model" is one answer. I mean, why would hospitals pay for ventilators they need now, but won't need later, without being incentivized? It's only lives after all, and their investors need to eat too.

The other answer is the Bernie Sanders solution: It's an emergency; government steps in and does the job only government can do. Government funds the ventilator company and mandates the ventilators by hospitals be purchased and made available. After all, during World War II the investment community didn't decide how many jeeps GM would produce — GM was told what to produce and complied.

This is as true today as it was a month ago: There is no neoliberal solution to this problem. Barring a miracle cure, we'll solve it the Sanders way or we won't solve it at all.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Thomas Neuburger

Thomas Neuburger

Thomas Neuburger is an essayist, poet and story writer. He has published political analysis under the pen name Gaius Publius since 2010.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

2.5 Million Nurses Demand UN Probe Into 'Covid-19 Criminals' Blocking Patent Waiver

The European Union, the United Kingdom, Switzerland, Norway, and Singapore "must be investigated for blocking a faster global vaccine rollout leading to the loss of countless lives."

Jake Johnson ·


WHO, South Africa Urge Nations to Lift 'Naive' Omicron Travel Bans

"The only thing the prohibition on travel will do is to further damage the economies of the affected countries and undermine their ability to respond to, and recover from, the pandemic."

Brett Wilkins ·


EU Joins Rights Group in Condemning Israel's 'Day of Destruction' of Palestinian Homes

"Demolitions are illegal under international law and significantly undermine the prospects for peace."

Brett Wilkins ·


GOP 'Silence Speaks Volumes,' Says Ilhan Omar as Boebert's Bigotry Goes Unpunished

"Normalizing this bigotry not only endangers my life but the lives of all Muslims. Anti-Muslim bigotry has no place in Congress."

Brett Wilkins ·


Africans Should Be 'Applauded, Not Punished,' Say Advocates Amid Omicron Travel Ban

"What is going on right now is inevitable," said African Union Vaccine Delivery Alliance co-chair Dr. Ayoade Alakija. "It's a result of the world's failure to vaccinate in an equitable, urgent, and speedy manner."

Brett Wilkins ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo